5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.91▼ | 5.90▼ | 5.89▼ | 5.83▲ | 5.34▲ |
MA10 | 5.92▼ | 5.88▼ | 5.88▼ | 5.50▲ | 5.39▲ |
MA20 | 5.92▼ | 5.86▲ | 5.84▲ | 5.13▲ | 5.57▲ |
MA50 | 5.89▼ | 5.90▼ | 5.66▲ | 5.50▲ | 4.93▲ |
MA100 | 5.87▲ | 5.63▲ | 5.27▲ | 5.39▲ | 3.59▲ |
MA200 | 5.84▲ | 5.23▲ | 4.96▲ | 4.92▲ | 4.05▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | 0.004▲ | -0.011▼ | 0.150▲ | -0.047▼ |
RSI | 40.382▼ | 51.291▲ | 54.291▲ | 62.601▲ | 55.751▲ |
STOCH | 28.077 | 73.098 | 76.668 | 81.821▲ | 40.126 |
WILL %R | -100.000▼ | -33.333 | -30.189 | -24.023▲ | -48.608 |
CCI | -211.143▼ | 50.061 | 63.218 | 100.122▲ | 5.917 |
CDL | $PSNL Harami Candlestick Pattern Detected | Set Alert |
Wednesday, September 10, 2025 01:17 PM
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced its collaboration with a leading breast cancer team from Yale Cancer Center for a clinical trial ...
|
Wednesday, September 03, 2025 01:14 PM
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial in lung cancer (NeoADAURA). The findings ...
|
Wednesday, August 27, 2025 08:01 AM
Detailed price information for Personalis Inc (PSNL-Q) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 5.83 | 5.95 | 5.71 | 5.87 | 643,600 |
15/09/25 | 5.88 | 5.95 | 5.68 | 5.93 | 634,645 |
12/09/25 | 6.06 | 6.06 | 5.68 | 5.85 | 1,006,890 |
11/09/25 | 5.39 | 6.255 | 5.37 | 6.10 | 1,524,832 |
10/09/25 | 5.44 | 5.565 | 5.32 | 5.39 | 936,175 |
09/09/25 | 5.34 | 5.455 | 5.255 | 5.39 | 692,396 |
08/09/25 | 5.28 | 5.40 | 5.21 | 5.32 | 760,961 |
05/09/25 | 5.12 | 5.27 | 5.04 | 5.24 | 857,120 |
04/09/25 | 4.89 | 5.115 | 4.73 | 5.09 | 980,056 |
03/09/25 | 4.80 | 4.91 | 4.79 | 4.85 | 828,100 |
|
|
||||
|
|
||||
|
|